A personalized mRNA vaccine, intisemran, developed by Moderna and MSD, demonstrated a significant reduction in the risk of melanoma returning or death in a global clinical trial.
A growing number of individuals under 50 are being diagnosed with Parkinson's disease, prompting a call for greater awareness of early warning signs.
A groundbreaking clinical trial led by an Australian scientist shows a new mRNA vaccine combined with immunotherapy significantly lowers the chances of melanoma returning or leading to death.
A custom-made mRNA vaccine combined with immunotherapy reduced the risk of recurrence or death by 42% in late-stage melanoma patients over two years.
An individual shares her struggle with health anxiety, detailing frequent doctor visits and constant symptom searching, while a psychologist outlines the condition's key signs and management strategies.
For the first time in six years, the NHS has achieved its goal of diagnosing two-thirds of over-65s with dementia, yet experts call for more ambitious targets and improved care.
The NHS has met its target for diagnosing dementia in two-thirds of over-65s, but experts and charities urge for more ambitious goals and faster access to care.
The virus, previously only known to affect cattle and other livestock, has been detected in a man in France who died in October.
A significant number of women suffer from recurrent urinary tract infections, experiencing severe pain and a diminished quality of life.